MedTrace Logo

Diagnostic Test for Endometrial Receptivity 24 Hours Before Embryo Transfer

NCT02189369 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2017-03-07

No results posted yet for this study

Summary

This clinical validation study is being carried out to validate the efficacy of a test measuring the clinical application of prostaglandins present in the endometrial fluid in patients, 24 hours before the embryonic transfer. This test is capable of predicting endometrial receptivity without the need of performing a biopsy.

Conditions

Interventions

OTHER

Day 3 embryo transfer

Extraction of endometrial fluid, analysis of prostaglandine and Day 3 embryo transfer

OTHER

Day 5 embryo transfer

Extraction of endometrial fluid, analysis of prostaglandine and Day 5 embryo transfer

Sponsors & Collaborators

  • Igenomix

    lead INDUSTRY

Principal Investigators

  • Carlos Simon, MD PhD · Fundación IVI

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2017-09-30
Completion
2017-12-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02189369 on ClinicalTrials.gov